Clinical trial
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
NCT04319627 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Statins for Venous Event Reduction in Patients With Venous Thromboembolism
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 10, 2021
- Completion date
- April 30, 2028
- Enrollment
- 2,700 (estimated)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
blood clot, post thrombotic syndrome, venous thromboembolism